Nucleus accumbens and amygdala are possible substrates for the aversive stimulus effects of opiate withdrawal
The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
Specific brain sites for the opiate abstinence syndrome syndrome have been elusive to delineate, and the classic overt signs of withdrawal such as wet dog shakes, ptosis and teeth chattering appear to be widely represented in the brain. Using a more general motivational test involving a disruption of operant behavior in dependent rats, the brain site most sensitive to the response disruptive effects of intracerebral administration of the opiate antagonist, methylnaloxonium, was the region of the nucleus accumbens, a site also implicated in the acute reinforcing properties of opiates. This disruption of operant responding was hypothesized to reflect the aversive properties of opiate withdrawal. The present study directly tested that hypothesis by exploring whether intercerebral administration of methylnaloxonium produced aversive stimulus effects as measured by the formation of place aversions. Rats implanted intracerebroventricularly or with bilateral cannulae aimed at the medial dorsal thalamus, periaqueductal gray, ventral tegmental area, amygdala or nucleus accumbens were made dependent on morphine by subcutaneous implantation of two 75-mg morphine pellets. The animals were then subjected to place aversion training by pairing of a distinct environment (one of three arms of a three-armed box with distinct texture, markings and smell) with a single injection of methylnaloxonium intracerebroventricularly or intracerebrally. Results showed that at high doses of methylnaloxonium (1000-2000 ng) all sites produced a place aversion. However, lower doses (250-500 ng) produced a significant brain site selectivity with the region of the nucleus accumbens the most sensitive. Observational measurements taken during the postinjection period with the high dose of methylnaloxonium showed that agitation was particularly observed following methylnaloxonium administration into the nucleus accumbens and periaqueductal gray.(ABSTRACT TRUNCATED AT 250 WORDS)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Other observed changes include increases in μ opioid receptor responsivity during opioid withdrawal,71,72 and decreases in GABAergic and increases in NMDA glutamatergic transmission in the nucleus accumbens.”
From Neurobiology of addiction: a neurocircuitry analysis (2016) · cites this paper as [71]
Citations
Cites
Nonparametric Statistics for the Behavioral Sciences
Guitton, H., & Siegel, S. (1958) · Revue économique · doi:10.2307/3498751 · Cited by 35,245
Nonparametric Statistics for the Behavioral Sciences.
Whitfield, J. W., & Siegel, S. (1957) · Journal of the Royal Statistical Society. Series A (General) · doi:10.2307/2342828 · Cited by 7,947
Goodman and Gilman's the Pharmacological Basis of Therapeutics
Stigelman, W. H., & Pharm, D. (1986) · Military Medicine · doi:10.1093/milmed/151.1.386 · Cited by 6,782
A stereotaxic atlas of the rat brain
Pellegrino, L. J., & Cushman, A. J. (1967) · Plenum Press eBooks · Cited by 4,688
A stereotaxic atlas of the rat brain
Brodal, P. (1980) · Neuroscience · doi:10.1016/0306-4522(80)90013-5 · Cited by 2,782
Cellular and molecular mechanisms of drug dependence
Koob, G. F., & Bloom, F. E. (1988) · Science · doi:10.1126/science.2903550 · Cited by 2,070
Self-citation[Drug addiction and drug abuse].
Feuerlein, W. (1969) · PubMed · Cited by 1,415
Goodman and Gilman's The Pharmacological Basis of Therapeutics
Fraunfelder, F. T. (1981) · American Journal of Ophthalmology · doi:10.1016/0002-9394(81)90318-4 · Cited by 1,331
Mucha, R. F., & Herz, A. (1985) · Psychopharmacology · doi:10.1007/bf00432213 · Cited by 510
Drug dependence: its significance and characteristics.
Eddy, N. O., Halbach, H., Isbell, H., & Seevers, M. H. (1965) · Europe PMC (PubMed Central) · Cited by 297
Research works printed but not linked: 1
- Adler, 1978, Inability of acute or chronic thalamic, limbic, or cortical lesions to alter narcotic dependence and abstinence in rats, Devl Neurosci., 4, 51
Cited by
Items 101–200 of 316
Watanabe, T., Nakagawa, T., Yamamoto, R., Maeda, A., Minami, M., & Satoh, M. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1504-0 · Cited by 71
“Stinus et al. (1990) showed that microinjection of methylnaloxonium, a hydrophilic opioid antagonist, into the CeA elicited CPA in morphine-dependent rats.”
BackgroundInfluentialZhang, Z., & Schulteis, G. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.01.013 · Cited by 77
Turchan-Cholewo, J. T., Lasoń, W., Budziszewska, B., & Przewłocka, B. (1997) · Neuropeptides · doi:10.1016/s0143-4179(97)90015-9 · Cited by 79
Done, C., Silverstone, P. H., & Sharp, T. (1992) · European Journal of Pharmacology · doi:10.1016/0014-2999(92)90052-6 · Cited by 69
Jackson, K. J., Sanjakdar, S. S., Muldoon, P. P., McIntosh, J. M., & Damaj, M. I. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.01.017 · Cited by 69
“…M anuscript N IH -PA Author M anuscript measure three different components of the affective nicotine withdrawal syndrome; brain reward/anhedonia (Stoker and Markou, 2011), anxiety (Handley and Mithani, 1984), and the aversive motivational component of withdrawal (Stinus et al., 1990), respectively.”
BackgroundMadhavan, A., Bonci, A., & Whistler, J. L. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.3366-10.2010 · Cited by 68
Distinct µ-opioid ensembles trigger positive and negative fentanyl reinforcement
Chaudun, F., Python, L., Liu, Y., Hiver, A., Cand, J., Kieffer, B. L., Valjent, E., & Lüscher, C. (2024) · Nature · doi:10.1038/s41586-024-07440-x · Cited by 76
Nakagawa, T., Yamamoto, R., Fujio, M., Suzuki, Y., Minami, M., Satoh, M., & Kaneko, S. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.03.029 · Cited by 67
Li, Y., Wang, H., Qi, K., Chen, X., Li, S., Sui, N., & Kirouac, G. J. (2011) · Physiology & Behavior · doi:10.1016/j.physbeh.2010.10.006 · Cited by 65
Hou, Y., Lu, B., Li, M., Liu, Y., Chen, J., Chi, Z., & Liu, J. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.1970-09.2009 · Cited by 68
How to design an opioid drug that causes reduced tolerance and dependence
Berger, A. C., & Whistler, J. L. (2010) · Annals of Neurology · doi:10.1002/ana.22002 · Cited by 65
Koob, G. F. (2017) · Psychopharmacology · doi:10.1007/s00213-016-4484-6 · Cited by 87
Self-citationBechara, A., Nader, K., & van der Kooy, D. (1995) · Behavioral Neuroscience · doi:10.1037//0735-7044.109.1.91 · Cited by 64
Acute opioid dependence: characterizing the early adaptations underlying drug withdrawal
Harris, A. C., & Gewirtz, J. C. (2005) · Psychopharmacology · doi:10.1007/s00213-005-2155-0 · Cited by 63
Flores, J. A., Galán-Rodríguez, B., Ramiro-Fuentes, S., & Fernández‐Espejo, E. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300946 · Cited by 62
Animal Models of Drug Addiction
Koob, G. F., & Moal, M. L. (2006) · Elsevier eBooks · doi:10.1016/b978-012419239-3/50039-4 · Cited by 62
Self-citationSubstance dependence as a compulsive behavior
Koob, G. F., Rocio, M., Carrera, A., Gold, L. H., Heyser, C. J., Maldonado-Irizarry, C., Markou, A., Parsons, L. H., Roberts, A. J., Schulteis, G., et al. (1998) · Journal of Psychopharmacology · doi:10.1177/026988119801200106 · Cited by 61
Self-citationRadke, A. K., & Gewirtz, J. C. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.97 · Cited by 63
Enoksson, T., Bertran‐Gonzalez, J., & Christie, M. J. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.02.020 · Cited by 65
Maldonado, R. J., Valverde, O., Garbay, C., & Roques, B. (1995) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00169392 · Cited by 61
Laorden, M. L., Ferenczi, S., Pintér-Kübler, B., González-Martín, L. L., Lasheras, M. C., Kovács, K. J., Milanés, M. V., & Núñez, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036871 · Cited by 55
“NAc shell has been related to the expression of morphine withdrawal somatic symptoms [15], together with the CeA and BNST [24,25].”
BackgroundRole of the limbic system in dependence on drugs
de Fonseca, F. R., & Navarro, M. (1998) · Annals of Medicine · doi:10.3109/07853899809029940 · Cited by 60
Skoubis, P. D., & Maidment, N. T. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00121-0 · Cited by 54
Ahmadi‐Soleimani, S. M., Azizi, H., Gompf, H. S., & Semnanian, S. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.08.024 · Cited by 57
Panagis, G., Hildebrand, B. E., Svensson, T. H., & Nomikos, G. G. (2000) · Synapse · doi:10.1002/(sici)1098-2396(200001)35:1<15::aid-syn3>3.0.co;2-c · Cited by 54
Šustková-Fišerová, M., Consolo, S., & Kršiak, M. (1999) · Psychopharmacology · doi:10.1007/s002130050866 · Cited by 56
Maldonado, R. J., Valverde, O., Turcaud, S., Fournié‐Zaluski, M., & Roques, B. P. (1994) · Pain · doi:10.1016/0304-3959(94)90186-4 · Cited by 53
Opioid actions on neurons of rat lateral amygdala in vitro
Sugita, S., & North, R. A. (1993) · Brain Research · doi:10.1016/0006-8993(93)91655-c · Cited by 53
Higgins, G. A., Nguyen, P., Joharchi, N., & Sellers, E. M. (1991) · Psychopharmacology · doi:10.1007/bf02244425 · Cited by 52
Trigeminal nerve stimulation: a current state-of-the-art review
Powell, K., Lin, K., Tambo, W., Saavedra, A. P., Sciubba, D. M., Abed, Y. A., & Li, C. (2023) · Bioelectronic Medicine · doi:10.1186/s42234-023-00128-z · Cited by 59
Sobieraj, J. C., Kim, A., Fannon, M. J., & Mandyam, C. D. (2014) · Brain Structure and Function · doi:10.1007/s00429-014-0905-7 · Cited by 55
Nader, K., Bechara, A., Roberts, D. C. S., & van der Kooy, D. (1994) · Behavioral Neuroscience · doi:10.1037//0735-7044.108.6.1128 · Cited by 55
Daunais, J. B., Letchworth, S. R., Sim‐Selley, L. J., Smith, H. R., Childers, S. R., & Porrino, L. J. (2001) · Journal of Comparative Neurology · doi:10.1002/cne.1154 · Cited by 49
Zarrindast, M., Karami, M., Sepehri, H., & Sahraei, H. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)02328-2 · Cited by 51
Conditioned place aversion to the “hangover” phase of acute ethanol administration in the rat
Morse, A. C., Schulteis, G., Holloway, F. A., & Koob, G. F. (2000) · Alcohol · doi:10.1016/s0741-8329(00)00099-9 · Cited by 48
Self-citationEasterling, K. W., & Holtzman, S. G. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36572-3 · Cited by 48
Stinus, L., Robert, C., Karasinski, P., & Limoge, A. (1998) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(97)00319-5 · Cited by 49
Self-citationSvingos, A. L., Cheng, P. Y., Clarke, C. L., & Pickel, V. M. (1995) · Brain Research · doi:10.1016/0006-8993(95)00977-x · Cited by 49
Madhavan, A., He, L., Stuber, G. D., Bonci, A., & Whistler, J. L. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.4634-09.2010 · Cited by 52
Heroin self-administration in dependent Wistar rats: increased sensitivity to naloxone
Carrera, M. R. A., Schulteis, G., & Koob, G. F. (1999) · Psychopharmacology · doi:10.1007/s002130050983 · Cited by 48
Self-citationWatanabe, T., Yamamoto, R., Maeda, A., Nakagawa, T., Minami, M., & Satoh, M. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03468-6 · Cited by 44
An Anatomical Basis for Opponent Process Mechanisms of Opiate Withdrawal
Radke, A. K., Rothwell, P. E., & Gewirtz, J. C. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.0172-11.2011 · Cited by 44
The potential role of the orexin reward system in future treatments for opioid drug abuse
Zarrabian, S., Riahi, E., Karimi, S., Razavi, Y., & Haghparast, A. (2018) · Brain Research · doi:10.1016/j.brainres.2018.11.023 · Cited by 44
Liu, S., Zhou, W., Liu, H., Yang, G., & Zhao, W. (2005) · Brain Research · doi:10.1016/j.brainres.2005.02.075 · Cited by 42
Forcelli, P. A., & Heinrichs, S. C. (2008) · Addiction Biology · doi:10.1111/j.1369-1600.2007.00078.x · Cited by 43
Severe Deficit in Brain Reward Function Associated with Fentanyl Withdrawal in Rats
Bruijnzeel, A. W., Lewis, B., Bajpai, L. K., Morey, T. E., Dennis, D. M., & Gold, M. S. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.07.020 · Cited by 45
Capriles, N., & Cancela, L. M. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00746-3 · Cited by 51
NMDA antagonists and clonidine block c‐fos expression during morphine withdrawal
Rasmussen, K., Brodsky, M., & Inturrisi, C. E. (1995) · Synapse · doi:10.1002/syn.890200110 · Cited by 43
Popik, P., Kozela, E., Wróbel, M., Wozniak, K. M., & Slusher, B. S. (2002) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300048 · Cited by 44
Differential effects of endocannabinoid catabolic inhibitors on morphine withdrawal in mice
Gamage, T. F., Ignatowska-Jankowska, B. M., Muldoon, P. P., Cravatt, B. F., Damaj, M. I., & Lichtman, A. H. (2015) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2014.11.015 · Cited by 40
“While the locus coeruleus appears important for the expression of somatic withdrawal signs, the amygdala and nucleus accumbens have been suggested to be more sensitive to naloxone-precipitated withdrawal and mediate the aversive components (Frenois et al., 2002; Hand et al., 1988; Stinus et al., 1990).”
BackgroundOpioid withdrawal: role in addiction and neural mechanisms
Monroe, S. C., & Radke, A. K. (2023) · Psychopharmacology · doi:10.1007/s00213-023-06370-2 · Cited by 53
Glass, M. J., Vanyo, L., Quimson, L., & Pickel, V. M. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.07.020 · Cited by 45
Przewłocka, B., Turchan-Cholewo, J. T., Lasoń, W., & Przewłocki, R. (1996) · Neuroscience · doi:10.1016/s0306-4522(96)83012-0 · Cited by 41
Rada, P. V., Colasante, C., Skirzewski, M., Hernandez, L., & Hoebel, B. G. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.03.043 · Cited by 42
Differential effects of μ and κ opioid antagonists on Fos-like immunoreactivity in extended amygdala
Carr, K. D., Kutchukhidze, N., & Park, T. H. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01088-4 · Cited by 43
Hellemans, K. G. C., Dickinson, A., & Everitt, B. J. (2006) · Behavioral Neuroscience · doi:10.1037/0735-7044.120.1.103 · Cited by 42
Cabral, A., Ruggiero, R. N., Nobre, M. J., Brandão, M. L., & Castilho, V. M. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.12.012 · Cited by 40
Espejo, E. F., Cador, M., & Stinus, L. (1995) · Psychopharmacology · doi:10.1007/bf02246086 · Cited by 41
Self-citationRasmussen, K., Martin, H. M., Berger, J. E., & Seager, M. A. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.09.010 · Cited by 38
Valverde, O., Tzavara, E. T., Hanoune, J., Roques, B. P., & Maldonado, R. J. (1996) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1996.tb01562.x · Cited by 41
Kelsey, J. E., & Arnold, S. R. (1994) · Behavioral Neuroscience · doi:10.1037//0735-7044.108.6.1119 · Cited by 38
Clonidine blocks acquisition but not expression of conditioned opiate withdrawal in rats
Schulteis, G. (1998) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00036-0 · Cited by 37
“Distinctive visual and tactile cues distinguished the three compartments (for details, see Stinus et al. 1990).”
Neurobiology of drug addiction.
Koob, G. F., Caine, S. B., Hyytiä, P., Markou, A., Parsons, L. H., Roberts, A. J., Schulteis, G., & Weiss, F. (1999) · American Psychological Association eBooks · doi:10.1037/10341-008 · Cited by 41
Self-citationRada, P. V., & Hoebel, B. G. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.12.016 · Cited by 39
Diaz, S. L., Barros, V. G., Antonelli, M. C., Rubio‐Terres, C., & Balerio, G. N. (2006) · Synapse · doi:10.1002/syn.20279 · Cited by 39
Effects of ceftriaxone on hydrocodone seeking behavior and glial glutamate transporters in P rats
Alshehri, F. S., Hakami, A. Y., Althobaiti, Y. S., & Sari, Y. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.03.043 · Cited by 37
Buccafusco, J. J., Terry, A. V., & Shuster, L. C. (1995) · Brain Research · doi:10.1016/0006-8993(95)00203-3 · Cited by 36
Glass, M. J., Hegarty, D. M., Oselkin, M., Quimson, L., South, S. M., Xu, Q., Pickel, V. M., & Inturrisi, C. E. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.04.045 · Cited by 36
Differential Modulation of Nucleus Accumbens Synapses
Brundege, J. M., & Williams, J. T. (2002) · Journal of Neurophysiology · doi:10.1152/jn.00766.2001 · Cited by 37
Matsumoto, M., Yoshioka, M., Togashi, H., Hirokami, M., Tochihara, M., Ikeda, T., Smith, C. B., & Saito, H. (1994) · Brain Research · doi:10.1016/0006-8993(94)90169-4 · Cited by 35
The effect of exposure to drugs on the processing of natural rewards
Anselme, P. (2008) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2008.10.002 · Cited by 43
David, V., & Cazala, P. (2000) · Psychopharmacology · doi:10.1007/s002130000425 · Cited by 38
Rada, P. V., & Hoebel, B. G. (2001) · Brain Research · doi:10.1016/s0006-8993(00)02865-1 · Cited by 34
Noble, F., Fournié‐Zaluski, M., & Roques, B. P. (1993) · European Journal of Pharmacology · doi:10.1016/0014-2999(93)90796-k · Cited by 33
Rasmussen, K., Hsu, M.-A., & Vandergriff, J. L. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2003.11.013 · Cited by 33
Walters, C. L., Aston-Jones, G., & Druhan, J. P. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00113-5 · Cited by 36
Neurobiological mechanisms of nicotine craving
Miyata, H., & Yanagita, T. (2001) · Alcohol · doi:10.1016/s0741-8329(01)00144-6 · Cited by 45
Impact of nicotine withdrawal on novelty reward and related behaviors.
Besheer, J., & Bevins, R. A. (2003) · Behavioral Neuroscience · doi:10.1037/0735-7044.117.2.327 · Cited by 33
Horowitz, J. M., Kristal, M. B., & Torres, G. (1997) · Synapse · doi:10.1002/(sici)1098-2396(199705)26:1<62::aid-syn7>3.0.co;2-c · Cited by 24
Cooper, A. H., Hedden, N. S., Corder, G. F., Lamerand, S. R., Donahue, R. R., Morales‐Medina, J. C., Selan, L., Prasoon, P., & Taylor, B. K. (2021) · Journal of Neuroscience Research · doi:10.1002/jnr.24846 · Cited by 31
Mu, L., Hou, Y., Lu, B., Chen, J., Chi, Z., & Liu, J. (2009) · Acta Pharmacologica Sinica · doi:10.1038/aps.2009.10 · Cited by 33
Jin, C., Araki, H., Nagata, M., Suemaru, K., Shibata, K., Kawasaki, H., Hamamura, T., & Gomita, Y. (2003) · Psychopharmacology · doi:10.1007/s00213-004-1844-4 · Cited by 35
Schulteis, G., Morse, A. C., & Liu, J. (2003) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2003.09.006 · Cited by 31
Olson, G. A., Olson, R. D., & Kastin, A. J. (1991) · Peptides · doi:10.1016/0196-9781(91)90227-g · Cited by 38
Chronic very low dose naltrexone administration attenuates opioid withdrawal expression
Mannelli, P., Gottheil, E., Peoples, J. F., Oropeza, V. C., & Bockstaele, E. J. V. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.05.013 · Cited by 30
Capriles, N., & Cancela, L. M. (2002) · Behavioural Brain Research · doi:10.1016/s0166-4328(01)00414-4 · Cited by 35
Wills, K. L., Vemuri, K., Kalmar, A., Lee, A., Limebeer, C. L., Makriyannis, A., & Parker, L. A. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3575-5 · Cited by 29
Rada, P. V., Mark, G. P., & Hoebel, B. G. (1993) · Brain Research · doi:10.1016/0006-8993(93)91601-n · Cited by 30
Johnson, P. I., & Stellar, J. R. (1994) · Brain Research · doi:10.1016/0006-8993(94)90059-0 · Cited by 32
Heinrichs, S. C., & Joppa, M. A. (2001) · Behavioural Brain Research · doi:10.1016/s0166-4328(01)00174-7 · Cited by 29
Src‐dependent phosphorylation of μ‐opioid receptor at Tyr336 modulates opiate withdrawal
Zhang, L., Kibaly, C., Wang, Y., Xu, C., Song, K. Y., McGarrah, P. W., Loh, H. H., Liu, J., & Law, P. (2017) · EMBO Molecular Medicine · doi:10.15252/emmm.201607324 · Cited by 27
Different neural systems mediate morphine reward and its spontaneous withdrawal aversion
Vargas-Pérez, H., Ting‐A‐Kee, R. A., & van der Kooy, D. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.06749.x · Cited by 29
Zhou, Q., Frändberg, P., Kindlundh, A. M. S., Grevès, P. L., & Nyberg, F. (2003) · Peptides · doi:10.1016/s0196-9781(02)00287-5 · Cited by 29
Zhou, Q., Karlsson, K., Liu, Z., Johansson, P., Grevès, M. L., Kiuru, A., & Nyberg, F. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(01)00055-7 · Cited by 28
Wills, K. L., & Parker, L. A. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00187 · Cited by 33
Guillem, K., Vouillac‐Mendoza, C., Koob, G. F., Cador, M., & Stinus, L. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.04.029 · Cited by 29
Self-citationLindblom, N., de Villiers, S. H. L., Semenova, S., Kalayanov, G., Gordon, S. L., Schilström, B., Johansson, A. M., Markou, A., & Svensson, T. H. (2005) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-005-0019-0 · Cited by 28
Harris, A. C., Atkinson, D. M., Aase, D. M., & Gewirtz, J. C. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.01.048 · Cited by 25
Sekiya, Y., Nakagawa, T., 徹, 小., Minami, M., & Satoh, M. (2003) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2003.11.062 · Cited by 26
Honkanen, A., Chrapusta, S. J., Karoum, F., & Korpi, E. R. (1994) · Alcohol · doi:10.1016/0741-8329(94)90099-x · Cited by 25
Metadata
- Authors
- Stinus, L., Le Moal, M., & Koob, G. F.
- Affiliations
- Inserm (FR)
- Scripps Research Institute (US)
- Corresponding author
- Koob, G.F.
- ORCID
- Koob, G.F.
- Venue
- Neuroscience
- Publisher
- Elsevier BV
- Published
- 1990-01
- Volume
- 37
- Issue
- 3
- Pages
- 767-773
- ISSN
- 0306-4522 (ISSN-L)
- OpenAlex
- W2043787639
- Cited by
- 317
- References
- 23
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 1 · 2023: 5 · 2022: 1 · 2021: 4 · 2020: 6 · 2019: 7 · 2018: 7 · 2017: 8 · 2016: 5 · 2015: 5 · 2014: 6 · 2013: 5 · 2012: 6
- FWCI
- 2.41
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Drug Abuse (NIDA04043, R01DA004043)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Keywords
- opioid withdrawal, nucleus accumbens, amygdala, place aversion, morphine dependence, periaqueductal gray, mediodorsal thalamus, ventral tegmental area, intracerebral administration, agitation
- MeSH terms
- Quaternary Ammonium Compounds, Amygdala, Animals, Conditioning, Operant, Injections, Intraventricular, Male, Morphine Dependence, Naloxone, Nucleus Accumbens, Rats, Inbred Strains, Substance Withdrawal Syndrome, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.